Norbrook Laboratories Ltd has launched Cleanor, an ear cleaner for cats and dogs.
Norbrook says Cleanor Ear Cleaner has been developed for regular, routine cleaning to help remove excessive ear wax from the ear canal as well as providing a moisturising effect to the ear canal's delicate epithelium.
Michelle Jones, Norbrook Brand Manager (Small Animals) said: "Ear disease represents one of the most common skin problems seen in veterinary practice. Checking the cat or dog's ears should be part of the normal health routine for pet owners. Cleanor Ear Cleaner has been designed to make the ear cleaning process simple and stress free for both the animal and owner. It comes with a long, soft and flexible nozzle to allow easy access to the ear canal and is gentle enough to treat even the most sensitive ears."
Cleanor Ear Cleaner is available in two sizes: 50ml and 120ml. It is supported by educational brochures to assist veterinary practices in discussing good ear cleaning practice with their clients. The brochures are available through Norbrook's local sales representatives.
Cleanor Ear Cleanor is available in the UK, Northern Ireland and the Republic of Ireland.
Bayer Animal Health has launched a free mobile app for pet owners, offering a bespoke parasite treatment reminder service, to help them follow their parasite protection plan prescribed by their vet.
The app was launched following a survey that found that 65% of pet owners do not regularly use parasite treatment products and are not certain that their pet is adequately protected against fleas, ticks, lice, mites and intestinal worms1. In addition, 83% of owners do not realise full protection against parasites requires a combination of two or more treatment products, and 45% are not confident that they have the job under control2.
The app allows owners to develop an on-going parasite protection plan in line with their veterinary prescription and receive automated reminders on treatment dates. In addition, the app allows users to set reminders for vaccination boosters, other vet appointments, and entering special dates like their pet's birthday or grooming appointments.
Once downloaded, users can create a pet profile to keep track of all their information in one place, including breed details, microchip number, weight, and date of birth of their dogs, cats, rabbits and ferrets. A 'learn' section of the app is also available to provide owners with the general information about parasites and the risk they pose to pets and family members.
The Jungle for Pets app is initially available to download for iPhones and iPads, by searching 'Jungle for Pets' in the Apple App store or clicking here.
VetSurgeon downloaded the app to try it out. A very polished app which has the potential to be extremely useful for those of us that can't remember our own names, let alone when the dog is due to be wormed. Three problems we found, which will doubtless be ironed out in future updates: Firstly, whilst the app works on an iPad, it's sized for and looks better on an iPhone. Secondly, it demanded a photo of the dog for registration. Whilst that's easy enough to do with an iPhone, the app then froze when we tried. Perhaps it should be optional. Finally, whilst the app very usefully allows for reminders of non-Bayer products, it doesn't appear to allow the user to type in the name of the product, forcing it to be listed as 'other'. We suspect that anyone who can't remember treatment dates (probably most of us) also won't be able to remember what 'other' was, especially if there are more than one or two 'other' products.
References
Ceva Animal Health has announced the launch of Vectra Felis, a new spot-on flea treatment for cats.
The new product contains two active ingredients: dinotefuran and pyriproxyfen. The first is an adulticide which Ceva says kills fleas on contact, thereby stopping fleas biting before they die. The second ingredient is an Insect Growth Regulator (IGR) which prevents flea reproduction and adult flea emergence, so protecting the cat and its environment from future flea attacks.
According to the company, Vectra Felis ensures that over 95% of fleas are killed within two hours and the effects last for a month.
In addition, Ceva highlights the product's patented applicator, which has an elongated smooth tip for quick and easy application. The company says it also provides accurate dosing and facilitates clean administration as nothing comes out until the tube is squeezed. Kittens can be treated from seven weeks of age (weighing at least 0.6kg).
For further information on Vectra Felis, contact your local Ceva territory manager or call 01494 781510.
The toolkit is part of a major study, the ‘Old Age Pets (OAP) research project’, recently funded by BSAVA PetSavers at the University of Liverpool.
The ACT includes an owner checklist for home triage and a leaflet which explains the more common health problems affecting aged dogs.
There's a practice waiting room poster which includes a QR code to give clients access to a digital version of the leaflet.
The leaflet recommends working through the checklist at least every six months and keeping completed versions for comparison, to monitor dogs as they age.
PetSavers says that some clients may benefit from advice and guidance from RVNs or PCAs on how to complete the checklist for the first time.
BSAVA has also curated a collection of articles, podcasts, lectures and book chapters to support veterinary professionals in caring for senior dogs: http://www.bsavalibrary.com/petsaversact.
Professor Carri Westgarth from the University of Liverpool said: “We conducted this research project kindly funded by BSAVA PetSavers in order to help owners and veterinary professionals provide great care for our loved pets as they age.
“Our investigations uncovered common physical and behavioural signs in dogs that owners observe and for which support from the veterinary practice would be beneficial.
"Our simple evidence-based checklist is designed to engage owners and importantly stimulate efficient discussion with their veterinary team.”
Free digital copies of the leaflet and poster can be downloaded here: http://www.bsavalibrary.com/content/cilgrouppetsaversact, where veterinary professionals can also request free printed copies for their practices.
https://www.bsava.com/petsavers/our-impact/citizen-science-project.
Kate, who has worked in practice for 30 years, said: "Pilates does more than just give you a strong core. By tapping into your mental wellbeing even for a short period, it allows that disconnection from the pressures of the day, and encourages the mind to press that reset button. We draw attention to our breathing, our physical well-being, and our mental health.
"By introducing practice pilates once or twice a week, you will find your staff will feel relaxed, mentally calm and engaged. You will also begin to find that they will suffer less and less with those aches and pains brought on by sitting for long periods, and so will suffer less with, and even eradicate lower back pain."
"By helping you practice pilates together as a team, I aim to nurture friendships, allay any clustering of personalities and provide a stable platform for all to be equal."
Practice Pilates has a network of instructors which are allocated to certain regions around the country, and Kate says the aim is to roll out the service, and cluster visits in each area, to keep costs low.
Sessions typically last 45 minutes to one hour, so they can fit into a lunch break.
The company offers a monthly subscription which provides slightly lower per class rates, or a Pay As You Go option. The service is being launched with reduced rate taster sessions.
For information, telephone Kate on 07780 603534 or email: practicepilates@outlook.com.
Speakers include Prof. Jo Dukes McEwan, Head of Service, Professor in Small Animal Cardiology (University of Liverpool), Doctor Jennifer Schissler, Veterinary Dermatologist, Best Friends Animal Hospital & Urgent Care Unit (US), and Doctor Pascal Prélaud, Dermatologist, CEO ADVETIA Vet Hospital Center (France).
Participants will also be able to access to an immersive experience, the Vet Symposium Village, which includes the Live Stage, Vet Lab, Clinic Lounge, and Innovation Hub, all offering exclusive videos and lectures.
The event will be translated into Chinese, French, Spanish, Italian, Portuguese, Russian, and German, and a replay of the event will be available until the end of the year.
Dr. Jennifer Welser, Chief Medical Officer, Mars Veterinary Health, said: “It’s more critical than ever for pet professionals from various countries, fields, and perspectives to meet and share their knowledge.
"I look forward to participating in the Vet Symposium and speaking with my peers on topics ranging from mental health to advancements in quality medical care and retaining veterinary talent.”
https://digital-vetsymposium2022.com/
Medichem International has produced an A4 sized laminated poster which illustrates the correct way to wash and disinfect hands thoroughly.
The poster has a sticky back enabling it to be placed near to hand washing facilities in the practice.
If you would like copies of the poster, they are available free of charge by emailing info@medichem.co.uk and stating your name, practice, address and postcode.
The Royal College of Veterinary Surgeons (RCVS) has clarified the legal position regarding the disbudding of goats, following recent media reports concerning undercover filming on UK goat farms.
The carrying out of any activity which amounts to veterinary surgery is restricted to veterinary surgeons unless there is a suitable exemption that allows other people to do it. The removal of the horn-bud of goats (disbudding) is considered veterinary surgery under the provisions of the Veterinary Surgeons Act 1966 (the Act).
Schedule 3 of the Act provides certain exemptions to the restriction on carrying out veterinary surgery, such as those allowing veterinary nurses and student veterinary nurses to undertake any medical treatment or any minor surgery (not involving entry into a body cavity) in certain circumstances. However, Schedule 3 specifically provides that these exemptions do not allow non-veterinary surgeons to undertake the disbudding of goats, except the trimming of the insensitive tip of an in-growing horn which, if left untreated, could cause pain or distress.
There are no other Exemption Orders covering the disbudding of goats and therefore this procedure may only be undertaken by veterinary surgeons.
The Mutilations (Permitted Procedures) (England) Regulations 2007, the Mutilations (Permitted Procedures) (Wales) Regulations 2007 and the Prohibited Procedures on Protected Animals (Exemptions) (Scotland) Regulations 2007 all include disbudding of goats as a procedure which can be carried out for non-therapeutic reasons. However, this secondary legislation is subject to the restrictions in the Veterinary Surgeons Act 1966 and therefore disbudding of goats is restricted to veterinary surgeons.The Welfare of Animals (Permitted Procedures By Lay Persons) Regulations (Northern Ireland) 2012 currently include disbudding of goats as a procedure which may be carried out by non-veterinary surgeons. However, the Veterinary Surgeons Act 1966 applies to Northern Ireland and the Regulations are scheduled to be amended later in 2012. This will make it clear that only veterinary surgeons may disbud goats in the UK.
The secondary legislation in the UK does not explicitly require anaesthetic to be administered when disbudding goats. However, disbudding should be carried out by veterinary surgeons in accordance with good practice and in such a way as to minimise pain and suffering caused to the animal, which should include use of an anaesthetic.
In summary, only a veterinary surgeon may undertake the disbudding of goats and due to the nature of the procedure, veterinary surgeons disbudding goats should administer anaesthetic.
Bayer Animal Health has launched Baytril® Max 100mg/ml Solution for Injection for Cattle and Pigs, which replaces the company's previously animal-specific Baytril Max products.
Bayer says the active ingredient, enrofloxacin, treats bacterial infection by inhibiting the action of bacterial DNA gyrase resulting in bacterial cell death.
In cattle, Baytril Max treats respiratory infections and mastitis caused by enrofloxacin-sensitive Histophilus somni, Mannheimia haemolytica, Pasteurella multocida and Mycoplasma spp., and enrofloxacin-sensitive E. coli respectively.
In pigs, Baytril Max targets bacterial bronchopneumonia caused by enrofloxacin-sensitive Actinobacillus pleuropneumoniae, Pasteurella multocida and complicated by Haemophilus parasuis as a secondary pathogen in pigs.
Bayer advises that vets treating cattle for respiratory infections should inject subcutaneously. Mastitis cases should be treated intravenously and pigs should be injected intramuscularly in the neck muscles, behind the ear.
The development of the Baytril Max product family provides vets with greater treatment flexibility from one solution.
For further information please visit www.noahcompendium.co.uk
The two 60-minute interactive sessions are taking place on Wednesday (21st April) at 12.30pm and 6pm, coinciding with the United Nation’s World Creativity and Innovation Day.
Each session will introduce a range of creative techniques that can be used to spur innovation. Different breakout groups will then have various problems to solve and will utilise these techniques to tackle challenges and issues encountered within everyday veterinary practice.
Sophie Rogers, RCVS ViVet Manager, said: "These creativity techniques are a framework for approaching problems, but the key to developing solutions to everyday tasks and problems is learning how to foster and harness the whole team's creative abilities. These workshops will provide the techniques to help you and your team overcome the common barriers to creativity and gain the tools and mindsets needed to break existing patterns and ways of doing things, generate new ideas, and improve creative self-leadership.”
The workshops will be hosted by Gill Stevens (pictured right), the Founding Director of Level Seven, a consultancy that specialises in merging coaching with design thinking methodology as a way to support innovation and team productivity, and Rick Harris, Founder of Customer Faithful, a research-led consultancy, specialising in customer research, proposition design and employee engagement.
Veterinary professionals can sign up to the sessions, which count towards their continuing professional development (CPD) requirement, via the ViVet website at: www.vivet.org.uk/interactive-workshop-on-creative-thinking/
The PFMA says the factsheets have been produced with nutrition experts in response to demand from industry professionals.
Nicole Paley, Deputy Chief Executive, PFMA said: "We launched our factsheet range just over a year ago to tackle and dispel many of the myths around pet food. The range now covers sixteen subjects and with over 3,400 downloads, they have proved to be a valuable resource for pet professionals at the front line of pet care.
"We decided to add the Vegetarian Diets Factsheet and Food Allergy and Intolerance Factsheet to our range in response to demand for clarification on these topics. Owners are exploring alternative diets and whilst cats are obligate carnivores, dogs are omnivores and can adapt to vegetarian diets. As with all diets, they need to be well-balanced and our factsheet contains top tips.
"The Allergy Factsheet explains the difference between allergies and intolerances, which are both adverse food reactions but are very different conditions requiring different advice from veterinary professionals."
To see the full range of PFMA factsheets, visit: pfma.org.uk/fact-sheets.
Pockit Central is a benchtop analyser which completes tests in 85 minutes.
The new PCR tests include: Lyme disease, Dirofilaria immitis, Neospora caninum, Pseudomonas aeruginosa, Mec A gene for MRSA, IBR and C. difficile. The system has tests tailored to small animal, equine and farm practice, with specialist assays also available for poultry and aquaculture.
The new additions extend the capabilities of the Pockit to more than 190 assays, testing up to 8 pathogens in one run. Horiba says the Pockit is so easy to set up that a laboratory can be up and running within 30 minutes with staff training provided.
Horiba has also published its recent veterinary CPD webinar in which the value of in-house PCR analysis for pathogen screening is discussed with the Head of ESCCAP (European Scientific Council for Companion Animal Parasites) UK & Ireland, in conjunction with the importance of screening imported dogs: The webinar is available to watch on-demand at: https://www.horiba.com/en_en/veterinary/support/webinars/
The solution, which Virbac says can also help eliminate bad breath, has been given a fresh new blue colour as well as a new bottle with a more contemporary design.
Claire Lewis, Junior Product Manager at Virbac, said: "Vet Aquadent is tried and trusted by many pet owners and relied upon for the contribution it makes to maintaining oral and dental health in dogs and cats.
"Blue is a popular colour in the veterinary dental sector so we wanted to bring Vet Aquadent in line with other related products to help ensure that it is instantly recognisable, both to existing and new users.
"It sits alongside the other products in our ‘at-home’ veterinary dental range, including our Enzymatic toothpastes which inhibit bacterial growth and our highly palatable VeggieDent chews, which are available in four sizes."
"Given the number of pets suffering from periodontal disease, encouraging pet owners to adopt an effective preventative care regime is a simple way for veterinary practices to encourage responsible pet ownership and, in so doing, generate a useful revenue stream from product sales."
The ioLight microscope fits in a jacket pocket and the company says it is both simple to use and robust. It unfolds to record and share 5MP still images and real time HD video at a magnification of x200 on an iPad Air. The resolution is 1 micron or 1/1,000 mm, powerful enough to see the structure of plant and animal cells.
The microscope uses standard microscope slides and has adjustable top and bottom illumination for use on both biological and opaque samples.
Iolight says it is particularly good for live samples which deteriorate on the journey back to the lab, and it works anywhere, even without a WiFi or mobile phone network.
Andrew Monk, who founded ioLight with business partner Richard Williams, said: "It takes just a couple of minutes to get a great image on the microscope, anywhere from a river bank to a factory floor. This makes microscopy simpler for everyone, from experienced professionals to student scientists."
The ioLight microscope can be ordered now from www.iolight.co.uk, priced at £840 including VAT.
In the past, all practices that offered Carefree Credit to clients had to complete the FCA authorisation process, something which involved completing a 48 page online application and a wait of 12 weeks for approval. Although Carefree Credit provides guidance with the process and around 700 practices have enrolled successfully, it was not the ideal solution for practices who wanted a quick solution.
From now on, those practices that are happy to offer interest-free credit for a maximum period of 12 months can do so without going through the FCA process.
Stewart Halperin MRCVS, the founder of Carefree Credit, said: "For those of you who have looked at a client finance option for your practice but have been put off by the thought of going through the FCA authorisation process, this will make things much easier."
For more information, visit www.carefreecredit.co.uk/
The RCVS Operational Board has announced that it will ask Council to review its decision to remove postgraduate postnominals from the Register, following the largely negative response from the profession to the idea, including a petition from Derbyshire surgeon, Victoria Lilley.
The original decision was made by Council in June 2012 as part of a package of measures aimed at developing clarity around postgraduate skills and knowledge.
The College says that the removal of postgraduate postnominals from the Register was intended to help dispel confusion amongst the public and some members of the profession about the level of various qualifications, by introducing the Advanced Practitioner status alongside the existing Specialist list.
Chairman of the Operational Board, CEO Nick Stace, said: "Over the last few days we have listened to the disquiet amongst the profession - which has included direct contact with staff and Operational Board members, a petition and discussion on fora and social media - and feel that we should address some misunderstandings but also give Council the opportunity to review the decision at its 5 June meeting.
"Many good points have been made by members of the profession and I am pleased that the Operational Board has agreed to reflect on them and consider whether there is a better way to achieve the clarity we were seeking for the public and the profession.
"The introduction of Advanced Practitioner status is a positive move for both the profession and the public, and underlines the College's commitment to lifelong learning.
"It is important to have the profession's support for the direction we are taking in advancing standards across the sector."
The College has also provided some Q&A's concerning the original decision made by Council in 2012, as follows.
Intervet/Schering-Plough Animal Health has announced the launch of Nuflor Minidose - a 50% more concentrated, but less viscous solution of its proven Nuflor antibiotic.
Nuflor Minidose is licensed for the treatment and prevention of bacterial BRD. Intervet/Schering-Plough Animal Health livestock veterinary adviser Rosemary Booth MRCVS said: "It delivers all the rapid efficacy entrusted in Nuflor, but at a lower volume. Whereas a 20ml dose of Nuflor will treat a 150kg animal, the same volume of Nuflor Minidose will cover a 225kg beast. Compared with Nuflor, the new Minidose formulation is easier to administer delivering a less viscous florfenicol solution, with a 62% improvement in viscosity at 15°C and 59% at 5°C."
Rosemary added that Nuflor Minidose is effective against the main bacterial causes of pneumonia: P. multocida, M. haemolytica and H. somni. "Florfenicol is the only antibiotic offering 100% sensitivity to these three key BRD causes in recent trials and its kill effect also ensures that within 24 hours bacteria levels are low enough to prevent any re-growth."
She also pointed out that the new, more concentrated florfenicol solution presents vets with an improved batch treatment option for controlling BRD considering Nuflor is recognised as an effective metaphylactic
"Batch treatment prevents BRD from spreading. Trials with Nuflor have demonstrated the benefit of metaphylactic batch treatment of sick calves in a pen once at least 20% of the animals exhibit disease symptoms. Nuflor was significantly more efficacious than a control in preventing the spread of BRD in healthy calves exposed to infected animals," she explains.
"The bacteria responsible for BRD are found in the respiratory tract of healthy cattle and stress or a greater pathogen load - such as exposure to sick calves - can easily trigger disease. BRD bacterial numbers can double every 30 minutes and in 24 hours, one bacterium can multiply to billions. Batch treatment kills the bacteria before they multiply, release toxins and cause permanent lung damage."
New Nuflor Minidose is licensed for injection subcutaneously for the prevention of BRD at a dose rate of 4ml/45kg and has a 64-day meat withdrawal period.
People are invited to organise or join a walk to raise money for Canine Arthritis Management and its work to educate both dog owners and veterinary professionals about how even the smallest of changes can help to enhance the life of a dog with arthritis.
CAM highlights recent work from the Royal Veterinary College and University of Sydney through VetCompass, which highlighted some of the biggest welfare challenges facing our pet population including obesity, dental disease and osteoarthritis, with osteoarthritis identified as one of the most severe conditions.
Hannah said: "We need to start more conversations about arthritis; both dog owners and vets need to be more aware of the steps we can take to help prevent arthritis, and where dogs are affected, how we can take positive action to help them live fulfilled and comfortable lives."
Hannah says that arthritis is currently one of the biggest causes of owners choosing to euthanise their dogs, and she hopes that owners taking part in the walks will help spread the word that arthritis can be managed.
To find out more about the Big September Walks visit www.facebook.com/CAMBigSeptemberWalks
Norbrook Laboratories Ltd has launched a new addition to the Loxicom range: Loxicom 0.5mg/ml Oral Suspension for Cats.
Offering alleviation from inflammation and pain, Loxicom Oral Suspension for Cats is billed by Norbrook as 'the new cost-effective treatment for chronic musculo-skeletal disorders in cats that is bio-equivalent to the pioneer.'
The Loxicom range now offers vet practices a choice between 5mg/ml Solution for Injection for Dogs and Cats, 1.5mg/ml Oral Suspension for Dogs and now 0.5mg/ml Oral Suspension for Cats.
Loxicom Oral Suspension for Cats is available in a clear 15ml bottle allowing veterinary surgeons and their clients to monitor product levels and re-order when necessary. The packaging also includes a graduated syringe in 0.5kg increments (from 0.5-10kg) which plugs securely into the bottle allowing accurate, mess-free administration.
Norbrook's small animal range also includes Carprieve, a range of carprofen tablets and injection and Noroclav, the amoxycillin / clavulanic acid range of tablets and injection.
The AHT has published the first research paper of its kind which looks at idiopathic epilepsy (IE) in the Italian Spinoni, a breed where the prevalence of IE has been found to be 5.3%, compared to 0.6% estimated to be seen in dogs generally in UK first opinion practice.
Dr Luisa De Risio, Head of Neurology at the AHT and lead researcher on the paper, said: "Idiopathic epilepsy is the most common chronic neurologic disorder in dogs but it can be more common in some breeds than others, for example Irish Wolfhounds, Border Collies and Italian Spinoni. Sadly, we see a lot epileptic dogs in our clinic, including these breeds as well as Golden Retrievers and Labrador Retrievers, so research being undertaken at the AHT, and around the world, is very important in helping owners of dogs with epilepsy to be able to control the effects of the disease.
"The Italian Spinone is a wonderful breed but is highly affected by idiopathic epilepsy. To our knowledge, no one has conducted such a large-scale research study in this breed to be able to gain a better understanding of how the epilepsy manifests, how prevalent it really is and, importantly, which factors may contribute to survival in these dogs.
"With the backing of the Italian Spinone Club of Great Britain, the AHT was able to design a questionnaire for the research study and work with the Kennel Club to invite over 3,000 Kennel Club registered Italian Spinone owners to aid our research by completing the questionnaire.
"1,192 owners participated in the research and of this sample, 63 Italian Spinoni had IE. Owners of affected dogs were then invited to complete a further questionnaire and asked to make the dog's medical records available. This gave us a very large amount of data to analyse from which we were able to glean a lot of very useful information about the clinical characteristics of idiopathic epilepsy in Italian Spinoni."
The research also looked at survival times of those dogs in the study with IE. Survival was significantly longer in Italian Spinone with no cluster seizures and in Italian Spinone in which antiepileptic medication was initiated after the second seizure rather than after more than three seizures.
Luisa continued: "From this sample we were able to conclude that idiopathic epilepsy in this breed often has a severe presentation but starting treatment with antiepileptic medication after the second seizure, and aggressive treatment of cluster seizures, may improve the survival of these dogs.
"The input in treatment design and modulation by a specialist veterinary neurologist with expertise in canine epilepsy can help to optimise treatment success and the dog's quality of life.
"We hope these findings will help to increase veterinary knowledge and understanding of this horrible disease and give Italian Spinoni, and other affected breeds, the best chance of fighting IE.
"Epilepsy is one of the most complex and difficult diseases to treat, with several variables in any case, but it is important for owners not to give up hope and to seek a consultation with a veterinary neurologist who specialises in epilepsy, if possible."
The next phase of the AHT's research in the Italian Spinone is to identify the genetic basis of this condition, with the aim of identifying the genetic mutations responsible so that a genetic test could be created. This research is currently on-going in Italian Spinoni and Border Collies and requires more DNA samples from affected and unaffected dogs.
Luisa said: "A genetic test is the only way to successfully help breeders identify carriers and select matings which are most likely to produce unaffected dogs. However, the genetics, like the condition itself, are very complex so the development of such a test is still likely to be many years away. The most we can do for these lovely dogs now is to share these findings across the veterinary profession and to do our best to treat each dog as well as we can."
The full paper is titled 'Idiopathic Epilepsy in the Italian Spinone in the United Kingdom: Prevalence, Clinical Characteristics, and Predictors of Survival and Seizure Remission' and is published in the Journal of Veterinary Internal Medicine on an open-access basis.
Photo: © Caroline Granycome
Norbrook Laboratories has announced the addition of new indications to its Loxicom (meloxicam) products, two regarding its use in cats, and the other in calves.
Loxicom 5mg/ml solution for injection for dogs and cats is now indicated for the management of post-operative pain in cats. An injection given around the time of surgery can be followed up with a course of Loxicom 0.5 mg/ml oral suspension for cats. Alternatively, for cats where no follow-up oral treatment is possible, for example with feral cats, a larger dose of the injectable formulation can be given at the time of surgery.
Norbrook's EU Veterinary Advisor, Rebekah Dudek MRCVS, said: "Norbrook is pleased to be able to now offer vets two on-licence choices in relation to how they want to use their 5mg/ml meloxicam injection in cats. This gives vets the flexibility they need to be able to deal effectively with the wide variety of cases they see every day."
Loxicom 20mg/ml solution for injection for cattle, pigs and horses has now been licenced for the relief of post-operative pain following dehorning in calves.
Norbrook says that the use of a non-steroidal antiinflammatory drug (NSAID) alongside local anaesthetic has clear benefits for animal welfare, and that use at this time is also shown to offer economic benefits to the farmer, with increased food-conversion efficiency compared to untreated calves1.
Rebekah said: "Dehorning in calves has long been known as a painful procedure, with a negative impact on feed intake in the post-operative period. With our latest licence, Loxicom 20mg/ml can now be used for relief of this potentially economically important post-operative pain in calves."
Reference
An impurity was detected during stability monitoring. The impurity was isolated and the best estimate of identity indicated that the impurity is carprofen related.
The problem affects a limited number of batches and is identifiable through quality control testing. The concentration of the process impurity does not increase over time.
This recall is for the following batches only:
Norbrook is contacting wholesale dealers and veterinary surgeons to examine inventory and quarantine products subject to this recall.
For further information regarding the recall, contact Gary Mckee on 0044 2830 264435 or by email: gary.mckee@norbrook.co.uk
A new equine parasite supplement to the online peer-reviewed publication Parasites and Vectors has been published by Fort Dodge.
Entitled "Equine parasites: diagnosis and control - a current perspective," it contains papers on a range of topics including a major European resistance study into key anthelmintic molecules. It is authored by equine parasitology experts and opinion leaders from around the world and was first published in September 2009. It is freely available at http://www.parasitesandvectors.com/
The initiative will run until early 2019, and has been expanded to include cats as well as dogs. In the run up, Lintbells is also offering lunch and learn sessions to help practices implement the clinics.
The company reports that feedback from 50 veterinary surgeons, nurses and practice managers who took part in the initiative last year was encouragingly positive. 86% agreed or strongly agreed that they are now managing mobility issues more effectively in practice and 90% thought client compliance had increased.
96% said they thought vets, nurses and reception staff were communicating more effectively. 95% thought the training had improved staff morale. 94% of veterinary staff felt clients were more confident about managing their pet’s condition and 92% thought more mobility issues had been identified. 74% said they thought practice revenue had increased.
Lintbells Brand Manager, Gemma Cunningham said: "We’re really pleased to be able to help practices to provide support for pets with stiff joints. This year we’ve made some exciting additions to the practice pack based on our ongoing conversations and feedback. Mobility issues in cats are often overlooked and we want to raise awareness and help support owners. By including cats this time round we hope to assist practices with their efforts to encourage cat owners to have their less active and sedentary cats checked out."
Practices that want to register an interest in receiving a Mobility Matters pack can contact their local Lintbells Veterinary Business Development Executive or visit www.lintbellsvet.com.
The company says a combination of unprecedented demand for the product and logistics issues, together with an issue involving the manufacturer of the active ingredient, has resulted in a delay in receiving stock into the UK.
Animalcare says it has a shipment awaiting dispatch to the UK from its European manufacturing plant as soon as licensing is completed by the VMD, Home Office and European counterparts. There is another batch in production, expected into the UK in early March.
Kai Crawshaw, Product Manager at Animalcare, said: "We are working hard with the VMD and Home Office to expedite the import licensing process and also with our manufacturer to ensure we can get as much stock as quickly as possible back into the marketplace. We sincerely apologise to any clinics that are experiencing a shortage but are glad to say that stock is on the way."